Abstract
From January 1983 to December 1986 seventy-six previously untreated children with non-Hodgkin's lymphoma (NHL) were treated by combination chemotherapy. Burkitt's lymphoma patients were ineligible. The treatment regimens include intermittent chemotherapy and for non-localized patients, prophylactic central nervous system chemotherapy. Intrathoracic non-Hodgkin's lymphoma patients also had cranial prophylactic radiotherapy. Sixty-six patients (86.8%) achieved complete remission. Two year failure-free survival rate was 82.1% for localized (stage I and II) NHL and 53.3% for non-localized (stage III and IV) NHL patients. Failure-free survival did not differ significantly for the two major histologic diagnoses, but two year survival rate was lower in diffuse poorly differentiated lymphoblastic than undifferentiated non-Burkitt's lymphoma (50% versus 66.8% respectively). Failure-free survival rate was 53.7% in mediastinal disease and, 73.2% in abdominal disease at 24 months. Relapse rate was higher in mediastinal cases (46.1%) than primary abdominal cases (24.3%) at 24 months. Eleven (13.5%) died of treatment related sepsis. Although the overall survival rate was 72.4% at 2 years we need novel or more intensive programmes for mediastinal and non-localized disease.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson J. R., Wilson J. F., Jenkin D. T., Meadows A. T., Kersey J., Chilcote R. R., Coccia P., Exelby P., Kushner J., Siegel S. Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). N Engl J Med. 1983 Mar 10;308(10):559–565. doi: 10.1056/NEJM198303103081003. [DOI] [PubMed] [Google Scholar]
- Glatstein E., Kim H., Donaldson S. S., Dorfman R. F., Gribble T. J., Wilbur J. R., Rosenberg S. A., Kaplan H. S. Non-Hodgkin's lymphomas. VI. Results of treatment in childhood. Cancer. 1974 Jul;34(1):204–211. doi: 10.1002/1097-0142(197407)34:1<204::aid-cncr2820340131>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
- Link M. P. Non-Hodgkin's lymphoma in children. Pediatr Clin North Am. 1985 Jun;32(3):699–720. [PubMed] [Google Scholar]
- Mott M. G., Chessells J. M., Willoughby M. L., Mann J. R., Morris-Jones P. H., Malpas J. S., Palmer M. K. Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG). Br J Cancer. 1984 Oct;50(4):457–462. doi: 10.1038/bjc.1984.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mott M. G., Eden O. B., Palmer M. K. Adjuvant low dose radiation in childhood non-Hodgkin's lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG). Br J Cancer. 1984 Oct;50(4):463–469. doi: 10.1038/bjc.1984.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Murphy S. B., Hustu H. O. A randomized trial of combined modality therapy of childhood non-Hodgkin's lymphoma. Cancer. 1980 Feb 15;45(4):630–637. doi: 10.1002/1097-0142(19800215)45:4<630::aid-cncr2820450403>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
- Sullivan M. P., Boyett J., Pullen J., Crist W., Doering E. J., Trueworthy R., Hvizdala E., Ruymann F., Steuber C. P. Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded). Cancer. 1985 Jan 15;55(2):323–336. doi: 10.1002/1097-0142(19850115)55:2<323::aid-cncr2820550204>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
- Wollner N., Burchenal J. H., Lieberman P. H., Exelby P., D'Angio G., Murphy M. L. Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy. Cancer. 1976 Jan;37(1):123–134. doi: 10.1002/1097-0142(197601)37:1<123::aid-cncr2820370119>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
- Wollner N., Exelby P. R., Lieberman P. H. Non-Hodgkin's lymphoma in children: a progress report on the original patients treated with the LSA2-L2 protocol. Cancer. 1979 Dec;44(6):1990–1999. doi: 10.1002/1097-0142(197912)44:6<1990::aid-cncr2820440605>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]